Plandai Biotechnology, Inc. Announces New Product With Coyne Healthcare
LONDON, UNITED KINGDOM--(Marketwired - Feb 2, 2016) - Plandaí Biotechnology, Inc. (OTCQB: PLPL) ("Plandaí" or "the Company"), producer of the highly bioavailable Phytofare® catechin complex, today announced a license agreement with Coyne Healthcare for a new product which will utilize the Company's Pheroid® entrapped Phytofare® catechin complex -- trade named "ph²™"-- in a high-end consumer product for therapeutic and various other applications. Under the agreement, Plandaí will prepare the ph2 capsules for Coyne who will then bottle, package and sell the product, first in South Africa with an international launch targeted later this year.
ph2™ is the combination of the nano-entrapment system, Pheroid® with the Company's Phytofare® catechin complex. Pheroid® encapsulates, or entraps, the Phytofare® in a long-chain fatty-acid which both improves absorption and protects the Phytofare® against metabolization during the digestive process. Pheroid® is actively used worldwide for industrial and agricultural purposes and has been extensively tested in humans and animals where it has shown an ability to significantly increase the level of absorption of the entrapped particles into the bloodstream. The new Coyne Healthcare product represents the first application of Phytofare® and Pheroid® (branded "ph²™") in a commercial product intended for human use.
Callum Cottrell-Duffield, Vice President of Plandaí, commented, "Coyne Healthcare's vision for creating a high-end wellness product is represented by their insistence on using the best ingredients available and then packaging and marketing them in an exclusive format. Together we believe that customers are tired of buying products whose active ingredients simply fail to deliver the desired results. ph2™ provides customers with a therapeutic level of all 8 catechins and then protects these valuable, thermogenic-producing molecules until they reach the blood stream. We're excited to be working together and anticipate great things for their product."
Kevin Coyne, Managing Director of Coyne Healthcare, added, "Plandaí's ability to deliver ph² fits perfectly with our goal of ensuring that our products perform exactly as represented on the label. Most nutraceutical products use inferior ingredients, incorrectly assuming, for instance, that green tea is green tea. This simply isn't the case. Coyne Healthcare requires that a therapeutic level of the active ingredients make it to the blood stream intact and are then absorbed by the targeted cells. ph2™ does just that, making our new product the first of its kind in the world."
Founded in Cape Town, South Africa, Coyne Healthcare has been both developing and distributing high quality nutraceutical and food supplements since 2013. For additional information, visit: www.coynehealthcare.co.za.
About Plandaí Biotechnology, Inc.
Plandaí Biotechnology, Inc. and its subsidiaries develop highly phyto-available™ extracts. Plandaí Biotechnology controls every aspect of the process, from growing the raw materials on its farms in South Africa, to producing its proprietary Phytofare® extracts in-house, allowing the Company to guarantee the continuity of supply as well as quality control throughout the entire process. Targeted industries for the Company's products include beverage, cosmeceutical, wellness, nutraceutical, anti-aging, and pharmaceutical. For more information, please visit http://www.plandaibiotech.com.
ph2™ is the combination of the nano-entrapment system, Pheroid® with the Company's Phytofare® catechin complex. Pheroid® encapsulates, or entraps, the Phytofare® in a long-chain fatty-acid which both improves absorption and protects the Phytofare® against metabolization during the digestive process. Pheroid® is actively used worldwide for industrial and agricultural purposes and has been extensively tested in humans and animals where it has shown an ability to significantly increase the level of absorption of the entrapped particles into the bloodstream. The new Coyne Healthcare product represents the first application of Phytofare® and Pheroid® (branded "ph²™") in a commercial product intended for human use.
Callum Cottrell-Duffield, Vice President of Plandaí, commented, "Coyne Healthcare's vision for creating a high-end wellness product is represented by their insistence on using the best ingredients available and then packaging and marketing them in an exclusive format. Together we believe that customers are tired of buying products whose active ingredients simply fail to deliver the desired results. ph2™ provides customers with a therapeutic level of all 8 catechins and then protects these valuable, thermogenic-producing molecules until they reach the blood stream. We're excited to be working together and anticipate great things for their product."
Kevin Coyne, Managing Director of Coyne Healthcare, added, "Plandaí's ability to deliver ph² fits perfectly with our goal of ensuring that our products perform exactly as represented on the label. Most nutraceutical products use inferior ingredients, incorrectly assuming, for instance, that green tea is green tea. This simply isn't the case. Coyne Healthcare requires that a therapeutic level of the active ingredients make it to the blood stream intact and are then absorbed by the targeted cells. ph2™ does just that, making our new product the first of its kind in the world."
Founded in Cape Town, South Africa, Coyne Healthcare has been both developing and distributing high quality nutraceutical and food supplements since 2013. For additional information, visit: www.coynehealthcare.co.za.
About Plandaí Biotechnology, Inc.
Plandaí Biotechnology, Inc. and its subsidiaries develop highly phyto-available™ extracts. Plandaí Biotechnology controls every aspect of the process, from growing the raw materials on its farms in South Africa, to producing its proprietary Phytofare® extracts in-house, allowing the Company to guarantee the continuity of supply as well as quality control throughout the entire process. Targeted industries for the Company's products include beverage, cosmeceutical, wellness, nutraceutical, anti-aging, and pharmaceutical. For more information, please visit http://www.plandaibiotech.com.